Evidence map›Paper›PMID 31183640›Full record

ArticleAnnals of surgical oncology2019

Cardiorespiratory Comorbidity and Postoperative Complications following Esophagectomy: a European Multicenter Cohort Study.

F Klevebro, J A Elliott, A Slaman, B D Vermeulen, S Kamiya, C Rosman, S S Gisbertz, P R Boshier, J V Reynolds, I Rouvelas and 3 more

Registry-linked trialOpen access · hybridAbstract readMulticenter Study
In one paragraph

Article in Annals of surgical oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07691944 (Effect of VExUS Score-Guided Intraoperative Goal-Directed Fluid Therapy on Postoperative Pulmonary Complications in Elderly Patients Undergoing McKeown Minimally Invasive Esophagectomy), which is not on this map. Cited by 42 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 3 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07691944 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Effect of VExUS Score-Guided Intraoperative Goal-Directed Fluid Therapy on Postoperative Pulmonary Complications in Elderly Patients Undergoing McKeown Minimally Invasive Esophagectomy: A Randomized Controlled Trial

TypeobservationalSponsorFirst Affiliated Hospital of Chongqing Medical UniversityRan2026 to 2026Enrolled126ConditionsEsophageal Cancer (EsC), Postoperative Pulmonary Complications (PPCs)ArmsVExUS Score-Guided Intraoperative Goal-Directed Fluid Therapy
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 3 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Are age, comorbidity, and frailty associated with complications after minimally invasive esophagectomy? A multicenter cohort study.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2026
    Trial
  5. Article
  6. Review
  7. Article
  8. Postoperative pulmonary complications after esophagectomy: risk factors and prediction model.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Treatment of anastomotic leakage following Ivor Lewis esophagectomy-10 year experience from a Nordic center.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2024
    Article
  16. Article
  17. Measurement and optimization of perioperative risk among patients undergoing surgery for esophageal cancer.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 4 countries.

F KlevebroDepartment of Upper Abdominal Surgery, Centre for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden. fredrik.klevebro@ki.se.
J A ElliottDepartment of Surgery, Trinity College Dublin, Dublin, Ireland.
A SlamanDepartment of Surgery, Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.
B D VermeulenDepartment of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.
S KamiyaDepartment of Upper Abdominal Surgery, Centre for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.
C RosmanRadboud University, Nijmegen, The Netherlands.
S S GisbertzDepartment of Surgery, Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.
P R BoshierDepartment Surgery and Cancer, Imperial College London, London, UK.
J V ReynoldsDepartment of Surgery, Trinity College Dublin, Dublin, Ireland.
I RouvelasDepartment of Upper Abdominal Surgery, Centre for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.
G B HannaDepartment Surgery and Cancer, Imperial College London, London, UK.
M I van Berge HenegouwenDepartment of Surgery, Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.
S R MarkarDepartment Surgery and Cancer, Imperial College London, London, UK.
Imperial College London · GBKarolinska University Hospital · SETrinity College Dublin · IEUniversity of Amsterdam · NLAmsterdam University Medical Centers · NLKarolinska Institutet · SERadboud University Medical Center · NLRadboud University Nijmegen · NL

Funding

Cancer Research UK 27981
6 · The paper itself

Abstract

backgroundThe impact of cardiorespiratory comorbidity on operative outcomes after esophagectomy remains controversial. This study investigated the effect of cardiorespiratory comorbidity on postoperative complications for patients treated for esophageal or gastroesophageal junction cancer. PATIENTS AND

methodsA European multicenter cohort study from five high-volume esophageal cancer centers including patients treated between 2010 and 2017 was conducted. The effect of cardiorespiratory comorbidity and respiratory function upon postoperative outcomes was assessed.

resultsIn total 1590 patients from five centers were included; 274 (17.2%) had respiratory comorbidity, and 468 (29.4%) had cardiac comorbidity. Respiratory comorbidity was associated with increased risk of overall postoperative complications, anastomotic leak, pulmonary complications, pneumonia, increased Clavien-Dindo score, and critical care and hospital length of stay. After neoadjuvant chemoradiotherapy, respiratory comorbidity was associated with increased risk of anastomotic leak [odds ratio (OR) 1.83, 95% confidence interval (CI) 1.11-3.04], pneumonia (OR 1.65, 95% CI 1.10-2.47), and any pulmonary complication (OR 1.52, 95% CI 1.04-2.22), an effect which was not observed following neoadjuvant chemotherapy or surgery alone. Cardiac comorbidity was associated with increased risk of cardiovascular and pulmonary complications, respiratory failure, and Clavien-Dindo score ≥ IIIa. Among all patients, forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) ratio > 70% was associated with reduced risk of overall postoperative complications, cardiovascular complications, atrial fibrillation, pulmonary complications, and pneumonia.

conclusionsThe results of this study suggest that cardiorespiratory comorbidity and impaired pulmonary function are associated with increased risk of postoperative complications after esophagectomy performed in high-volume European centers. Given the observed interaction with neoadjuvant approach, these data indicate a potentially modifiable index of perioperative risk.

Indexed as

Postoperative ComplicationsAdenocarcinomaAgedCardiovascular DiseasesCohort StudiesComorbidityEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaEsophagectomyEsophagogastric JunctionEuropeFemaleFollow-Up StudiesHumansLength of StayMale

Identifiers

PMID31183640
PMCPMC6682565
OpenAlexW2950749378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.